NCT00516373 A Study to Assess the Safety and Pharmacokinetics
NCT00003120 Phase III Randomized Trial of 12 Months vs. 3
NCSP Monitoring and Evaluation: Cervical Cancer Case Reviews
NCSI Information Resource
NCRI Breast Cancer Clinical Studies Group
NCRI 2012 clinician poster - SHORE-C
NCRA Annual conference re
nCounter® v2 Cancer CN Assay
NCORP - Mary Bird Perkins Cancer Center
NCN newsletter June 2012 - Northern Cancer Network
NCI`s Patient-Reported Outcomes Version of the Common
NCIN overview Nov08 - National Statistical Service
NCIC CTG Abstracts to be presented at
NCIC CTG Abstracts to be presented at
NCI60 Cancer Cell Panel
NCI-UCLA Biomedical Consent Template
NCI-MATCH is an Example of What S
NCI-60 Cell Line Screening: A Radical Departure
NCI trial announcement
NCI SEER Public-Use Data: Applications and Limitations in
